Sham-Controlled Randomized Pilot Trial on Baroreflex Activation Therapy in Resistant Hypertension

Affiliations

• ¹ Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Finland (J.R.S., P.-H.G.).
• ² Department of Nephrology (J.R.S., P.-H.G., I.T., D.G.), University of Helsinki and Helsinki University Hospital, Finland.
• ³ Research Program for Clinical and Molecular Metabolism (J.R.S., P.-H.G.), Faculty of Medicine, University of Helsinki, Finland.
• ⁴ Minerva Foundation Institute for Medical Research, Helsinki, Finland (J.R.S., I.T., D.G.).
• ⁵ Department of Anesthesiology (L.V.), University of Helsinki and Helsinki University Hospital, Finland.
• ⁶ Department of Vascular Surgery (P.V.), University of Helsinki and Helsinki University Hospital, Finland.
• ⁷ Heart and Lung Center, Helsinki University and Helsinki University Central Hospital (M.L.).
• ⁸ Biostatistics Unit (H.G.-W.), Faculty of Medicine, University of Helsinki, Finland.
• ⁹ Department of Diabetes, Central Clinical School, Monash University, Melbourne, Victoria, Australia (P.-H.G.).
• ¹⁰ Helsinki Hypertension of Excellence (I.T., D.G.), University of Helsinki and Helsinki University Hospital, Finland.
• ¹¹ Joslin Diabetes Center, Harvard Medical School, Boston, MA (D.G.).